Canada markets closed

Outlook Therapeutics Inc. (41O.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
7.00-0.30 (-4.11%)
At close: 08:04AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-09-30
2022-09-30
2021-09-30
2020-09-30
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
21,120
26,453
42,331
38,958
26,342
Selling General and Administrative
26,642
26,673
20,740
12,769
9,971
Total Operating Expenses
47,761
53,126
63,071
51,727
36,313
Operating Income or Loss
-47,761
-53,126
-63,071
-51,727
-36,313
Interest Expense
-
1,560
1,487
936.127
1,756
Total Other Income/Expenses Net
-4,812
-4,294
-1,491
-498.486
-441.976
Income Before Tax
-51,496
-58,980
-66,049
-53,161
-38,511
Income Tax Expense
-
2.8
2.8
2
-3,272
Income from Continuing Operations
-51,498
-58,983
-66,052
-53,163
-35,239
Net Income
-51,498
-58,983
-66,052
-53,163
-35,239
Net Income available to common shareholders
-51,498
-58,983
-66,052
-53,163
-48,874
Basic EPS
-0.24
-4.80
-6.20
-7.00
-13.40
Diluted EPS
-0.24
-4.80
-6.20
-7.00
-13.40
Basic Average Shares
250,177
12,509
10,604
7,634
3,628
Diluted Average Shares
250,177
12,509
10,604
7,634
3,628